Video

Q&A With Richard Lewis, MD, FAAN, of Cedars Sinai: Taking the Next Steps in CIDP Treatment

Author(s):

As more is learned about the diagnosis and treatment of CIDP the medical community is also learning how best to work with patients with the condition.

As more is learned about the diagnosis and treatment of CIDP the medical community is also learning how best to work with patients with the condition.

There are mechanisms in place to monitor treatment success but Richard Lewis, MD, from Cedars Sinai said it is important to have people familiar with the condition to monitor patient health in order to assure them the best possible outcome. Lewis spoke during the American Academy of Neurology's annual meeting in Washington DC. 

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.